Back
Editas Medicine, Inc. Stock Price Chart
BlackRock's $91B Secret
Learn how to access Native Markets before Coinbase. Watch the free training.
Sell
22
EDIT
Editas Medicine, Inc.
Last Price:
$2.15
Seasonality Move:
-10.7%
7 Day Trial
ALL ACCESS PASS
$
7
Washington Wants Your Money. Here's How to Opt Out.
Learn how to become your own bank. Watch the free training.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EDIT is experiencing selling pressure, which indicates risk of future bearish movement.
Editas Medicine, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.15 | Sell |
| 20-day SMA: | 2.33 | Sell |
| 50-day SMA: | 2.61 | Sell |
| 200-day SMA: | 2.39 | Sell |
| 8-day EMA: | 2.14 | Sell |
| 20-day EMA: | 2.28 | Sell |
| 50-day EMA: | 2.33 | Sell |
| 200-day EMA: | 1.31 | Buy |
Editas Medicine, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.13 | Sell |
| Relative Strength Index (14 RSI): | 29.23 | Sell |
| Chaikin Money Flow: | -1164880 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.16 - 2.5) | Sell |
| Bollinger Bands (100): | (2.31 - 3.41) | Sell |
Editas Medicine, Inc. Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 24 | 26 | 29 | 30 | 31 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Editas Medicine, Inc. Stock
Is Editas Medicine, Inc. Stock a Buy?
-
Editas Medicine, Inc. share price is 1.99 while EDIT 8-day simple moving average is 2.15, which is a Sell signal.
-
The stock price of EDIT is 1.99 while Editas Medicine, Inc. 20-day SMA is 2.33, which makes it a Sell.
-
Editas Medicine, Inc. 50-day simple moving average is 2.61 while EDIT share price is 1.99, making it a Sell technically.
-
EDIT stock price is 1.99 and Editas Medicine, Inc. 200-day simple moving average is 2.39, creating a Sell signal.
EDIT Technical Analysis vs Fundamental Analysis
Sell
22
Editas Medicine, Inc. (EDIT)
is a Sell
Is Editas Medicine, Inc. a Buy or a Sell?
-
Editas Medicine, Inc. stock is rated a SellThe current Editas Medicine, Inc. [EDIT] share price is $1.99. The Score for EDIT is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
Editas Medicine, Inc. Stock Info
Market Cap:
194.3M
Price in USD:
1.99
Share Volume:
2.2M
Editas Medicine, Inc. 52-Week Range
52-Week High:
4.54
52-Week Low:
0.91
Sell
22
Editas Medicine, Inc. (EDIT)
is a Sell
Editas Medicine, Inc. Share Price Forecast
-
What is the Editas Medicine, Inc. stock price today?The Editas Medicine, Inc. stock price is 1.99 USD today.
-
Will EDIT stock go up or go down?Editas Medicine, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Editas Medicine, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Editas Medicine, Inc. is overvalued.
Is Editas Medicine, Inc. Stock a Buy?
-
Editas Medicine, Inc. share price is 1.99 while EDIT 8-day exponential moving average is 2.14, which is a Sell signal.
-
The stock price of EDIT is 1.99 while Editas Medicine, Inc. 20-day EMA is 2.28, which makes it a Sell.
-
Editas Medicine, Inc. 50-day exponential moving average is 2.33 while EDIT share price is 1.99, making it a Sell technically.
-
EDIT stock price is 1.99 and Editas Medicine, Inc. 200-day simple moving average is 1.31, creating a Buy signal.
Fundamental Analysis of Editas Medicine, Inc.
Is Editas Medicine, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.89 per share, and an increase next year of $0.08 per share.
Technical Analysis of Editas Medicine, Inc.
Should I short Editas Medicine, Inc. stock?
-
EDIT Moving Average Covergence Divergence (MACD) indicator is -0.13, suggesting Editas Medicine, Inc. is a Sell
-
Editas Medicine, Inc. Relative Strength Index (RSI) is 29.23, which suggest Editas Medicine, Inc. is oversold
-
The Bollinger Bands (25) for Editas Medicine, Inc. is (2.16 - 2.5), which suggest Editas Medicine, Inc. is a Sell
-
The Bollinger Bands (100) for Editas Medicine, Inc. is (2.31 - 3.41), which suggest Editas Medicine, Inc. is a Sell
* Editas Medicine, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.